521 related articles for article (PubMed ID: 9775403)
1. The regulation of amyloid precursor protein metabolism by cholinergic mechanisms and neurotrophin receptor signaling.
Rossner S; Ueberham U; Schliebs R; Perez-Polo JR; Bigl V
Prog Neurobiol; 1998 Dec; 56(5):541-69. PubMed ID: 9775403
[TBL] [Abstract][Full Text] [Related]
2. p75 and TrkA receptor signaling independently regulate amyloid precursor protein mRNA expression, isoform composition, and protein secretion in PC12 cells.
Rossner S; Ueberham U; Schliebs R; Perez-Polo JR; Bigl V
J Neurochem; 1998 Aug; 71(2):757-66. PubMed ID: 9681467
[TBL] [Abstract][Full Text] [Related]
3. The Intersection of NGF/TrkA Signaling and Amyloid Precursor Protein Processing in Alzheimer's Disease Neuropathology.
Canu N; Amadoro G; Triaca V; Latina V; Sposato V; Corsetti V; Severini C; Ciotti MT; Calissano P
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28632177
[TBL] [Abstract][Full Text] [Related]
4. Muscarinic acetylcholine receptor inhibition in transgenic Alzheimer-like Tg2576 mice by scopolamine favours the amyloidogenic route of processing of amyloid precursor protein.
Liskowsky W; Schliebs R
Int J Dev Neurosci; 2006; 24(2-3):149-56. PubMed ID: 16423497
[TBL] [Abstract][Full Text] [Related]
5. Memantine improves spatial learning and memory impairments by regulating NGF signaling in APP/PS1 transgenic mice.
Liu MY; Wang S; Yao WF; Zhang ZJ; Zhong X; Sha L; He M; Zheng ZH; Wei MJ
Neuroscience; 2014 Jul; 273():141-51. PubMed ID: 24846616
[TBL] [Abstract][Full Text] [Related]
6. Cholinergic activity and amyloid precursor protein processing in aging and Alzheimer's disease.
Zhang X
Curr Drug Targets CNS Neurol Disord; 2004 Apr; 3(2):137-52. PubMed ID: 15078189
[TBL] [Abstract][Full Text] [Related]
7. Huperzine A regulates amyloid precursor protein processing via protein kinase C and mitogen-activated protein kinase pathways in neuroblastoma SK-N-SH cells over-expressing wild type human amyloid precursor protein 695.
Peng Y; Lee DY; Jiang L; Ma Z; Schachter SC; Lemere CA
Neuroscience; 2007 Dec; 150(2):386-95. PubMed ID: 17945434
[TBL] [Abstract][Full Text] [Related]
8. Neurotrophin binding to the p75 neurotrophin receptor is necessary but not sufficient to mediate NGF-effects on APP secretion in PC-12 cells.
Rossner S; Ueberham U; Schliebs R; Perez-Polo JR; Bigl V
J Neural Transm Suppl; 1998; 54():279-85. PubMed ID: 9850936
[TBL] [Abstract][Full Text] [Related]
9. Cholinergic immunolesions by 192IgG-saporin--useful tool to simulate pathogenic aspects of Alzheimer's disease.
Rossner S
Int J Dev Neurosci; 1997 Nov; 15(7):835-50. PubMed ID: 9568532
[TBL] [Abstract][Full Text] [Related]
10. Cerebrolysin modulates pronerve growth factor/nerve growth factor ratio and ameliorates the cholinergic deficit in a transgenic model of Alzheimer's disease.
Ubhi K; Rockenstein E; Vazquez-Roque R; Mante M; Inglis C; Patrick C; Adame A; Fahnestock M; Doppler E; Novak P; Moessler H; Masliah E
J Neurosci Res; 2013 Feb; 91(2):167-77. PubMed ID: 23152192
[TBL] [Abstract][Full Text] [Related]
11. Amyloid precursor protein potentiates the neurotrophic activity of NGF.
Wallace WC; Akar CA; Lyons WE
Brain Res Mol Brain Res; 1997 Dec; 52(2):201-12. PubMed ID: 9495541
[TBL] [Abstract][Full Text] [Related]
12. Cortico-hippocampal APP and NGF levels are dynamically altered by cholinergic muscarinic antagonist or M1 agonist treatment in normal mice.
Seo H; Ferree AW; Isacson O
Eur J Neurosci; 2002 Feb; 15(3):498-506. PubMed ID: 11876777
[TBL] [Abstract][Full Text] [Related]
13. [Alzheimer disease: cellular and molecular aspects].
Octave JN
Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248
[TBL] [Abstract][Full Text] [Related]
14. Deletion of M1 muscarinic acetylcholine receptors increases amyloid pathology in vitro and in vivo.
Davis AA; Fritz JJ; Wess J; Lah JJ; Levey AI
J Neurosci; 2010 Mar; 30(12):4190-6. PubMed ID: 20335454
[TBL] [Abstract][Full Text] [Related]
15. Regulation of proteolytic processing of the amyloid beta-protein precursor of Alzheimer's disease in transfected cell lines and in brain slices.
Nitsch RM; Slack BE; Farber SA; Schulz JG; Deng M; Kim C; Borghesani PR; Korver W; Wurtman RJ; Growdon JH
J Neural Transm Suppl; 1994; 44():21-7. PubMed ID: 7897393
[TBL] [Abstract][Full Text] [Related]
16. Regulation of proteolytic processing of the amyloid beta-protein precursor by first messengers. A novel potential approach for the treatment of Alzheimer's disease.
Nitsch RM; Wurtman RJ; Growdon JH
Arzneimittelforschung; 1995 Mar; 45(3A):435-8. PubMed ID: 7763340
[TBL] [Abstract][Full Text] [Related]
17. NGF and the Amyloid Precursor Protein in Alzheimer's Disease: From Molecular Players to Neuronal Circuits.
Triaca V; Ruberti F; Canu N
Adv Exp Med Biol; 2021; 1331():145-165. PubMed ID: 34453297
[TBL] [Abstract][Full Text] [Related]
18. The phosphatidylinositol 3-kinase inhibitor wortmannin alters the metabolism of the Alzheimer's amyloid precursor protein.
Petanceska SS; Gandy S
J Neurochem; 1999 Dec; 73(6):2316-20. PubMed ID: 10582589
[TBL] [Abstract][Full Text] [Related]
19. Crosstalk between angiotensin and the nonamyloidogenic pathway of Alzheimer's amyloid precursor protein.
Kanarek AM; Wagner A; Küppers J; Gütschow M; Postina R; Kojro E
FEBS J; 2017 Mar; 284(5):742-753. PubMed ID: 28102934
[TBL] [Abstract][Full Text] [Related]
20. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
